| Glaxosmithkline Share Price | |||
|---|---|---|---|
| Price | 1,915.00 | Open | 1,925.00 |
| Bid | 1,913.00 | High | 1,927.50 |
| Ask | 1,913.50 | Low | 1,906.00 |
| Change | 0.50 (0.03%) | Close | 1,914.50 |
| Volume | 3,950,795 | ||
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 4.01b |
| Market Cap | £76.86b |
| PE Ratio | 13.57193 |
| EPS | 141.10 |
| Year High | 2,282.00 |
|---|---|
| Year High Date | 18-Feb-2026 |
| Year Low | 1,315.00 |
| Year Low Date | 18-Jul-2025 |
| Dividend | 63.00 |
| Yield | 3.29% |
| # Trades | 8,008 |
|---|---|
| Vol. Sold | 2,734,191 |
| Sold Value | £52.35m |
| Vol. Bought | 858,947 |
| Bought Value | £14.36m |
| Market Size | 1,000 |
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 22-May-26 | 15:28:23 | 1,919.00 | 0 | Unknown* | 1,913.00 | 1,913.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 22-May-26 | 16:51:21 | 1,925.00 | 268,103 | Unknown* | 1,913.00 | 1,913.50 | 5m | O Ordinary Was reported as OTC |
| 22-May-26 | 15:18:05 | 1,918.50 | 0 | Unknown* | 1,913.00 | 1,913.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 22-May-26 | 15:18:05 | 1,918.50 | 0 | Unknown* | 1,913.00 | 1,913.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 22-May-26 | 15:18:05 | 1,918.50 | 0 | Unknown* | 1,913.00 | 1,913.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 22-May-26 | 15:18:05 | 1,918.50 | 0 | Unknown* | 1,913.00 | 1,913.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 22-May-26 | 15:18:05 | 1,918.50 | 0 | Unknown* | 1,913.00 | 1,913.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 22-May-26 | 16:43:22 | 1,915.00 | 11 | Buy* | 1,913.00 | 1,913.50 | 210.65 | O Ordinary Trade was executed as an SI |
| 22-May-26 | 16:40:26 | 1,915.00 | 107 | Buy* | 1,913.00 | 1,913.50 | 2,049 | O Ordinary Trade was executed as an SI |
| 22-May-26 | 16:39:55 | 1,915.00 | 30 | Buy* | 1,913.00 | 1,913.50 | 574.50 | O Ordinary Trade was executed as an SI |
| Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|---|
| 20-May-26 | 15-May-26 | Buy | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 49.67 | USD | 74 | 15,323,778 |
| 19-May-26 | 15-May-26 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 49.67 | USD | 2,301 | 15,323,704 |
| 14-May-26 | 12-May-26 | Transfer From | Julie Brown held the position of Chief Finance Officer at the time of this trade.Julie Brown | 0.00 | 7 | 44,492 | |
| 14-May-26 | 12-May-26 | Buy | Julie Brown held the position of Chief Finance Officer at the time of this trade.Julie Brown | 1,865.59 | GBX | 7 | 44,492 |
| 29-Apr-26 | 29-Apr-26 | Buy | Wendy Becker held the position of Non-Executive Director at the time of this trade.Wendy Becker | 1,962.91 | GBX | 4,000 | 21,250 |
At GSK, we unite science, technology and talent to get ahead of disease together